(Note: For PDF File Swipe To The End Of Article)
Thyroid Disorders
Thyroid disorders are among the most common endocrine diseases affecting people worldwide. The thyroid gland is a small butterfly-shaped organ situated in the lower anterior part of the neck, just below the thyroid cartilage and in front of the trachea. Although small in size, the thyroid gland has an enormous influence on nearly every tissue and organ system in the body. It regulates metabolism, growth, development, body temperature, cardiovascular activity, gastrointestinal motility, mental function, and reproductive health through the secretion of thyroid hormones.
The thyroid gland primarily produces two hormones known as thyroxine (T4) and triiodothyronine (T3). These hormones are synthesized using iodine obtained from the diet. Their production is regulated through a feedback system involving the hypothalamus and pituitary gland. The hypothalamus secretes thyrotropin-releasing hormone (TRH), which stimulates the anterior pituitary gland to release thyroid-stimulating hormone (TSH). TSH then acts on the thyroid gland to stimulate hormone production and release. When circulating thyroid hormone levels rise, they inhibit TRH and TSH secretion through negative feedback mechanisms.
Any abnormality involving hormone production, secretion, regulation, or structural integrity of the thyroid gland can lead to thyroid disorders. These disorders may result in either excessive thyroid hormone production, known as hyperthyroidism, or inadequate hormone production, known as hypothyroidism. Structural disorders such as goiter, thyroid nodules, inflammatory conditions, autoimmune diseases, and malignancies can also occur.
Thyroid disorders can affect individuals of all ages, including newborns, children, adolescents, adults, pregnant women, and elderly individuals. Women are affected more frequently than men, particularly in autoimmune thyroid diseases such as Graves disease and Hashimoto thyroiditis. Many thyroid disorders develop gradually and may initially present with subtle symptoms, leading to delayed diagnosis if proper evaluation is not performed.
Anatomy and Physiology of the Thyroid Gland
The thyroid gland consists of two lateral lobes connected by a thin central isthmus. It is highly vascular and receives blood supply mainly from the superior and inferior thyroid arteries. Microscopically, the gland is composed of spherical structures called thyroid follicles. These follicles are lined by epithelial cells and contain colloid, which stores thyroglobulin, the precursor protein used in thyroid hormone synthesis.
The thyroid gland also contains parafollicular cells, also known as C cells, which secrete calcitonin. Calcitonin plays a role in calcium homeostasis by lowering blood calcium levels through inhibition of bone resorption.
The synthesis of thyroid hormones involves several important steps. First, iodide from the bloodstream is actively transported into thyroid follicular cells. Inside the gland, iodide is oxidized to iodine and attached to tyrosine residues on thyroglobulin through a process known as organification. Coupling reactions then form T3 and T4 molecules. These hormones remain stored in the colloid until stimulation by TSH causes their release into the bloodstream.
Although the thyroid secretes more T4 than T3, T3 is the biologically more active hormone. Most circulating T3 is formed by peripheral conversion of T4 in tissues such as the liver and kidneys through the action of deiodinase enzymes.
Thyroid hormones exert their effects by entering target cells and binding to nuclear receptors that regulate gene transcription. They increase metabolic activity, oxygen consumption, heat production, protein synthesis, and responsiveness to catecholamines. Their actions are essential for normal growth, neurological development, cardiovascular function, and energy balance.
Classification of Thyroid Disorders
Thyroid disorders may be classified into functional, structural, inflammatory, autoimmune, congenital, and neoplastic conditions. Functional disorders involve abnormalities in hormone production, whereas structural disorders involve enlargement, nodules, or tumors of the gland.
Hypothyroidism refers to deficient thyroid hormone production and results in slowing of metabolic processes. Hyperthyroidism refers to excessive thyroid hormone production and causes acceleration of metabolism and sympathetic nervous system activity.
Goiter refers to enlargement of the thyroid gland and may occur in association with normal, decreased, or increased thyroid function. Thyroid nodules are focal lesions within the gland that may be benign or malignant. Thyroiditis refers to inflammation of the thyroid gland and includes several autoimmune, infectious, and inflammatory conditions. Thyroid cancers arise from different thyroid cell types and vary greatly in aggressiveness and prognosis.
Congenital thyroid disorders are present at birth and can significantly impair growth and neurodevelopment if not recognized early. Autoimmune thyroid diseases are among the most important thyroid conditions and involve immune-mediated destruction or stimulation of thyroid tissue.
Hypothyroidism
Definition and Overview
Hypothyroidism is a clinical syndrome caused by insufficient production of thyroid hormones or inadequate action of thyroid hormones at the tissue level. It is one of the most common endocrine disorders and affects metabolism throughout the body. The condition may develop gradually over many years, leading to progressive slowing of physiological functions.
Hypothyroidism can be classified as primary, secondary, or tertiary. Primary hypothyroidism results from disease affecting the thyroid gland itself and accounts for the majority of cases. Secondary hypothyroidism results from pituitary dysfunction causing inadequate TSH secretion, whereas tertiary hypothyroidism arises from hypothalamic disease leading to deficient TRH production.
The severity of hypothyroidism ranges from mild subclinical disease to severe life-threatening myxedema coma. Early diagnosis and appropriate treatment are essential to prevent complications involving the cardiovascular, neurological, and reproductive systems.
Causes of Hypothyroidism
The causes of hypothyroidism vary worldwide depending on iodine intake and population characteristics. In iodine-sufficient regions, autoimmune thyroid disease is the leading cause, while iodine deficiency remains the major cause globally.
Hashimoto thyroiditis is the most common cause of primary hypothyroidism in many developed countries. It is an autoimmune condition in which lymphocytic infiltration and autoantibody-mediated destruction gradually impair thyroid function. The gland may initially enlarge but later becomes fibrotic and atrophic.
Iodine deficiency impairs thyroid hormone synthesis because iodine is an essential component of T3 and T4. Persistent deficiency leads to increased TSH secretion and thyroid enlargement in an attempt to compensate.
Hypothyroidism may also develop following thyroidectomy or radioactive iodine therapy used in the treatment of hyperthyroidism and thyroid cancer. Certain medications such as lithium, amiodarone, interferon-alpha, and tyrosine kinase inhibitors can interfere with thyroid hormone synthesis or release.
Congenital hypothyroidism occurs due to thyroid agenesis, ectopic thyroid tissue, enzyme defects in hormone synthesis, or maternal iodine deficiency. Central hypothyroidism may result from pituitary tumors, head trauma, radiation therapy, pituitary surgery, or hypothalamic disease.
Transient hypothyroidism can occur during subacute thyroiditis, postpartum thyroiditis, or recovery from severe illness.
Pathophysiology of Hypothyroidism
The deficiency of thyroid hormones leads to generalized slowing of metabolic processes throughout the body. Cellular oxygen consumption decreases, heat production falls, and energy utilization declines. Protein synthesis and carbohydrate metabolism are impaired, while lipid metabolism slows, leading to hypercholesterolemia and weight gain.
Reduced thyroid hormone activity decreases cardiac output by lowering heart rate and myocardial contractility. Gastrointestinal motility becomes sluggish, resulting in constipation. Neurological activity slows, producing fatigue, lethargy, depression, memory impairment, and delayed reflexes.
Accumulation of glycosaminoglycans within interstitial tissues contributes to the characteristic non-pitting edema known as myxedema. This process affects the skin, tongue, larynx, and other tissues, producing coarse facial features, hoarseness, and swelling.
In primary hypothyroidism, reduced circulating thyroid hormone levels stimulate compensatory elevation of TSH secretion by the pituitary gland. Chronic TSH stimulation may cause thyroid enlargement and goiter formation.
Clinical Features of Hypothyroidism
The clinical manifestations of hypothyroidism develop gradually and vary depending on age, severity, and duration of hormone deficiency. Early symptoms are often nonspecific and may resemble normal aging or other chronic illnesses.
Fatigue and generalized weakness are among the most common symptoms. Patients often complain of reduced physical activity, excessive sleepiness, poor concentration, and mental slowing. Weight gain despite reduced appetite is common due to decreased metabolic rate and fluid retention.
Cold intolerance is characteristic because impaired heat production reduces the body’s ability to tolerate low temperatures. The skin becomes dry, rough, pale, and cool. Hair may become coarse and brittle with diffuse hair thinning. Nails become fragile and slow-growing.
Facial puffiness, especially around the eyes, occurs due to myxedematous tissue infiltration. Speech may become slow and hoarse because of laryngeal edema and tongue enlargement. Bradycardia and reduced cardiac output may lead to exercise intolerance and fatigue.
Gastrointestinal motility decreases, causing constipation and abdominal bloating. Menstrual irregularities, infertility, decreased libido, and recurrent miscarriages may occur in women. In severe cases, hypothyroidism can impair ovulation and reproductive function.
Neurological manifestations include depression, impaired memory, slow thinking, hearing impairment, paresthesia, and delayed relaxation of deep tendon reflexes. Severe prolonged disease may result in psychosis known as myxedema madness.
Musculoskeletal symptoms include muscle cramps, stiffness, joint pain, and proximal muscle weakness. Hypercholesterolemia increases the risk of atherosclerosis and coronary artery disease.
In advanced untreated hypothyroidism, patients may develop myxedema coma, a life-threatening emergency characterized by hypothermia, altered consciousness, bradycardia, respiratory depression, hypotension, and multi-organ dysfunction.
Diagnosis of Hypothyroidism
The diagnosis of hypothyroidism is based on clinical evaluation, laboratory investigations, imaging studies in selected cases, and assessment of underlying causes. Because many symptoms are nonspecific and develop gradually, laboratory testing plays a crucial role in confirming the diagnosis.
The most sensitive and commonly used investigation is measurement of serum thyroid-stimulating hormone (TSH). In primary hypothyroidism, TSH levels are elevated because the pituitary gland attempts to stimulate the failing thyroid gland. Serum free thyroxine (free T4) levels are usually reduced. The combination of elevated TSH and low free T4 confirms overt primary hypothyroidism.
In subclinical hypothyroidism, TSH levels are elevated while free T4 remains within the normal range. Patients may or may not have symptoms. Subclinical disease is important because it can progress to overt hypothyroidism over time, particularly in patients with thyroid autoantibodies.
In secondary or central hypothyroidism caused by pituitary or hypothalamic disease, free T4 levels are low while TSH levels may be low, normal, or mildly elevated but biologically inactive. Therefore, TSH alone is insufficient for diagnosis in suspected pituitary disorders.
Measurement of thyroid autoantibodies is useful in identifying autoimmune thyroid disease. Anti-thyroid peroxidase antibodies and anti-thyroglobulin antibodies are frequently positive in Hashimoto thyroiditis. Their presence supports autoimmune etiology and may predict progression of subclinical disease.
Additional laboratory abnormalities may include hypercholesterolemia, elevated creatine kinase, anemia, hyponatremia, and elevated liver enzymes. Electrocardiography may reveal sinus bradycardia, low voltage complexes, or pericardial effusion in severe disease.
Thyroid ultrasound may be performed when structural abnormalities such as goiter or nodules are present. In Hashimoto thyroiditis, ultrasound often demonstrates a heterogeneous hypoechoic gland with increased vascularity during active inflammation.
Imaging of the pituitary gland with magnetic resonance imaging may be necessary in patients with suspected secondary hypothyroidism, especially if other pituitary hormone deficiencies or neurological symptoms are present.
Treatment of Hypothyroidism
The treatment of hypothyroidism primarily involves thyroid hormone replacement therapy using levothyroxine, a synthetic form of thyroxine (T4). Treatment aims to restore normal thyroid hormone levels, relieve symptoms, normalize metabolic function, and prevent complications.
Levothyroxine is administered orally and is usually taken once daily on an empty stomach to optimize absorption. Food, calcium supplements, iron preparations, antacids, and certain medications can interfere with absorption and should not be taken simultaneously.
The dosage of levothyroxine depends on factors such as age, body weight, severity of hypothyroidism, cardiovascular status, pregnancy, and coexisting illnesses. Young healthy adults may begin with full replacement doses, whereas elderly patients and individuals with coronary artery disease require lower initial doses to avoid cardiac complications.
Monitoring therapy is essential to ensure appropriate dosing. Serum TSH levels are generally rechecked six to eight weeks after initiation or adjustment of therapy because thyroid hormone equilibrium takes time to stabilize. Once adequate replacement is achieved, annual monitoring is often sufficient.
Overreplacement should be avoided because excessive thyroid hormone can cause palpitations, atrial fibrillation, osteoporosis, insomnia, anxiety, and weight loss. Underdosing may leave symptoms unresolved and allow complications to persist.
Treatment of central hypothyroidism differs because TSH cannot be used reliably for monitoring. Instead, free T4 levels and clinical response guide therapy.
Pregnant women with hypothyroidism require careful monitoring because thyroid hormone requirements increase during pregnancy. Inadequate treatment can lead to miscarriage, preeclampsia, preterm delivery, and impaired fetal neurological development.
Congenital hypothyroidism requires immediate initiation of levothyroxine to prevent irreversible intellectual disability and growth impairment. Newborn screening programs have significantly improved outcomes through early detection.
Myxedema coma is a medical emergency requiring intensive care treatment. Management includes intravenous thyroid hormone replacement, corticosteroids, ventilatory support, correction of electrolyte abnormalities, treatment of precipitating factors, and careful cardiovascular monitoring.
Hyperthyroidism
Definition and Overview
Hyperthyroidism is a clinical condition caused by excessive synthesis and secretion of thyroid hormones by the thyroid gland. The resulting elevation of circulating thyroid hormones accelerates metabolic activity and increases sympathetic nervous system responsiveness.
Thyrotoxicosis refers to the clinical state resulting from excess thyroid hormone exposure regardless of the source. Although hyperthyroidism is the most common cause of thyrotoxicosis, the term also includes conditions involving release of preformed hormones, excessive hormone ingestion, or ectopic hormone production.
Hyperthyroidism affects multiple organ systems and can vary from mild disease to severe life-threatening thyroid storm. Women are affected more frequently than men, and autoimmune Graves disease represents the most common cause in many populations.
Causes of Hyperthyroidism
Graves disease is the leading cause of hyperthyroidism. It is an autoimmune disorder characterized by production of thyroid-stimulating immunoglobulins that bind to and activate TSH receptors on thyroid follicular cells. This stimulation results in diffuse thyroid enlargement and excessive hormone production.
Toxic multinodular goiter is another important cause and occurs when multiple autonomously functioning thyroid nodules produce excess hormones independent of pituitary control. It is more common in older individuals and regions with longstanding iodine deficiency.
Toxic adenoma refers to a single autonomously functioning thyroid nodule producing excessive thyroid hormones. Unlike Graves disease, the remainder of the thyroid tissue is usually suppressed.
Thyroiditis may cause transient thyrotoxicosis due to release of preformed thyroid hormones from damaged follicular cells. Subacute thyroiditis, postpartum thyroiditis, and silent thyroiditis are common examples.
Excessive intake of thyroid hormone medication can also produce thyrotoxicosis. Rare causes include TSH-secreting pituitary adenomas, struma ovarii, and trophoblastic disease.
Certain medications such as amiodarone may induce hyperthyroidism through iodine-related mechanisms or inflammatory thyroid injury.
Pathophysiology of Hyperthyroidism
Excess thyroid hormones increase basal metabolic rate and oxygen consumption in nearly all tissues. Heat production rises, causing heat intolerance and excessive sweating. Protein catabolism accelerates, resulting in muscle wasting and weight loss despite increased appetite.
Cardiovascular effects are prominent because thyroid hormones increase beta-adrenergic receptor sensitivity. Heart rate, cardiac output, and myocardial contractility increase significantly. Persistent tachycardia may lead to atrial fibrillation and heart failure, especially in elderly patients.
Neurological and psychiatric manifestations arise from increased sympathetic nervous system activity. Patients may experience nervousness, anxiety, irritability, emotional instability, tremors, insomnia, and hyperreflexia.
Gastrointestinal motility increases, leading to frequent bowel movements or diarrhea. Bone turnover accelerates, predisposing to osteopenia and osteoporosis.
In Graves disease, autoimmune inflammation also affects orbital tissues, producing thyroid eye disease characterized by exophthalmos, diplopia, eyelid retraction, and orbital edema.
Clinical Features of Hyperthyroidism
The symptoms and signs of hyperthyroidism reflect excessive metabolic activity and adrenergic stimulation. Weight loss despite normal or increased appetite is one of the most characteristic findings. Patients often complain of excessive sweating, heat intolerance, palpitations, nervousness, tremors, and fatigue.
Cardiovascular manifestations include tachycardia, widened pulse pressure, systolic hypertension, atrial fibrillation, and increased cardiac output. Persistent untreated disease may result in high-output heart failure.
Neurological symptoms include anxiety, irritability, emotional lability, insomnia, hyperactivity, and fine tremors of the hands. Deep tendon reflexes are typically brisk.
Muscle weakness and proximal myopathy may impair climbing stairs or rising from chairs. Increased protein catabolism contributes to muscle wasting and fatigue.
The skin becomes warm, moist, and smooth because of increased blood flow and sweating. Hair may become fine and thin. Some patients develop diffuse hyperpigmentation or onycholysis.
Gastrointestinal symptoms include increased bowel frequency and diarrhea. Women may experience oligomenorrhea, amenorrhea, or infertility, while men may develop gynecomastia and erectile dysfunction.
In Graves disease, diffuse goiter is common. Eye manifestations include lid lag, lid retraction, exophthalmos, conjunctival irritation, diplopia, and periorbital edema. Severe eye disease may threaten vision due to optic nerve compression or corneal ulceration.
Elderly patients may present atypically with fatigue, depression, weight loss, and atrial fibrillation rather than overt adrenergic symptoms. This presentation is sometimes termed apathetic hyperthyroidism.
Diagnosis of Hyperthyroidism
The diagnosis of hyperthyroidism is established through careful clinical assessment, thyroid function testing, antibody studies, and imaging investigations when necessary. Because symptoms may overlap with anxiety disorders, cardiac disease, and metabolic conditions, laboratory confirmation is essential.
Serum thyroid-stimulating hormone (TSH) is the most sensitive initial screening test. In primary hyperthyroidism, TSH levels are markedly suppressed due to negative feedback from elevated circulating thyroid hormones. Measurement of free thyroxine (free T4) and triiodothyronine (T3) confirms the diagnosis. Many patients demonstrate elevated free T4 and T3 levels, although some may have isolated elevation of T3, a condition known as T3 toxicosis.
Autoimmune antibody testing is particularly useful in Graves disease. Thyroid-stimulating immunoglobulins or TSH receptor antibodies are often elevated and help confirm autoimmune etiology. Anti-thyroid peroxidase antibodies may also be present.
Radioactive iodine uptake scanning is valuable for determining the cause of thyrotoxicosis. In Graves disease, uptake is diffusely increased throughout the gland. Toxic multinodular goiter demonstrates patchy uptake corresponding to autonomously functioning nodules, while toxic adenoma produces focal uptake in a single nodule. In thyroiditis, uptake is usually very low because hormone release occurs from destruction of follicles rather than increased synthesis.
Thyroid ultrasound with Doppler imaging may demonstrate diffuse enlargement and increased vascularity in Graves disease. Ultrasound is also important for identifying nodules, cysts, or structural abnormalities requiring further evaluation.
Electrocardiography often reveals sinus tachycardia or atrial fibrillation. Laboratory studies may show hypercalcemia, elevated liver enzymes, reduced cholesterol levels, and mild anemia. Bone density assessment may be indicated in longstanding disease because accelerated bone turnover increases osteoporosis risk.
In suspected pituitary-mediated hyperthyroidism, TSH levels may be inappropriately normal or elevated despite high thyroid hormone levels. Magnetic resonance imaging of the pituitary gland may reveal a TSH-secreting adenoma.
Treatment of Hyperthyroidism
The treatment of hyperthyroidism aims to reduce thyroid hormone production, relieve symptoms, prevent complications, and address the underlying cause. The main treatment options include antithyroid medications, radioactive iodine therapy, surgery, and supportive therapy with beta blockers.
Beta blockers are commonly used early in treatment to control adrenergic symptoms such as palpitations, tremors, anxiety, and tachycardia. Propranolol is particularly useful because it also reduces peripheral conversion of T4 to T3 at high doses.
Antithyroid drugs inhibit thyroid hormone synthesis within the gland. Methimazole is the preferred medication in most patients because of its effectiveness and lower risk of severe liver toxicity. Propylthiouracil is generally reserved for the first trimester of pregnancy, thyroid storm, or patients intolerant to methimazole.
These medications inhibit thyroid peroxidase, thereby preventing iodination and coupling reactions involved in hormone synthesis. Propylthiouracil additionally inhibits peripheral conversion of T4 to T3.
Patients receiving antithyroid therapy require regular monitoring because adverse effects may occur. Minor side effects include rash, itching, arthralgia, and gastrointestinal upset. Serious complications include agranulocytosis, hepatotoxicity, and vasculitis. Fever or sore throat in treated patients requires urgent evaluation because it may indicate severe neutropenia.
Radioactive iodine therapy is a widely used definitive treatment for Graves disease and toxic nodular hyperthyroidism. Radioactive iodine is selectively taken up by thyroid cells and destroys tissue through localized radiation. Gradual reduction in hormone production occurs over weeks to months.
Many patients eventually develop hypothyroidism following radioactive iodine therapy and require lifelong levothyroxine replacement. Radioactive iodine is contraindicated during pregnancy and breastfeeding because it may damage fetal or neonatal thyroid tissue.
Surgical treatment through thyroidectomy is indicated in selected situations including large goiters causing compressive symptoms, suspicion of thyroid cancer, severe ophthalmopathy, medication intolerance, recurrent hyperthyroidism, or patient preference.
Before surgery, patients should be rendered euthyroid using antithyroid medications and beta blockers to reduce operative risk. Potassium iodide solutions may be administered preoperatively to decrease thyroid vascularity.
Complications of thyroid surgery include hypocalcemia due to parathyroid injury, recurrent laryngeal nerve damage causing hoarseness, bleeding, infection, and postoperative hypothyroidism.
Long-term follow-up is essential after treatment because recurrence, hypothyroidism, or persistent eye disease may develop over time.
Graves Disease
Definition and Overview
Graves disease is an autoimmune disorder characterized by diffuse toxic goiter, hyperthyroidism, ophthalmopathy, and occasionally dermopathy. It is the most common cause of hyperthyroidism in young and middle-aged adults and occurs far more frequently in women than men.
The disease results from production of thyroid-stimulating immunoglobulins that bind to TSH receptors on thyroid follicular cells, mimicking the action of TSH and stimulating uncontrolled hormone synthesis and thyroid growth.
Genetic susceptibility plays an important role, and environmental factors such as stress, smoking, infection, and iodine exposure may contribute to disease development.
Pathophysiology of Graves Disease
In Graves disease, autoreactive lymphocytes stimulate production of antibodies directed against TSH receptors. These antibodies continuously activate the receptor independent of pituitary regulation, leading to excessive synthesis and secretion of thyroid hormones.
The thyroid gland becomes diffusely enlarged and hypervascular due to follicular hyperplasia and increased blood flow. Histologically, tall crowded follicular epithelial cells and scalloping of colloid are characteristic findings.
Autoimmune inflammation also affects tissues outside the thyroid gland, especially orbital fibroblasts and dermal tissues. Cytokine release and glycosaminoglycan deposition within orbital tissues cause edema, muscle enlargement, and exophthalmos.
Smoking significantly increases the severity and risk of thyroid eye disease in Graves disease patients.
Clinical Features of Graves Disease
Patients with Graves disease exhibit manifestations of hyperthyroidism along with characteristic autoimmune findings. Diffuse symmetrical enlargement of the thyroid gland is common and may produce a bruit because of increased vascularity.
Eye findings are among the most distinctive features. Eyelid retraction and lid lag are frequent, while more severe ophthalmopathy may produce exophthalmos, periorbital edema, conjunctival redness, excessive tearing, double vision, and impaired eye movement.
Some patients develop pretibial myxedema, a localized infiltrative dermopathy usually affecting the anterior lower legs. The skin becomes thickened, raised, and waxy due to glycosaminoglycan deposition.
Acropachy, characterized by digital clubbing and periosteal bone formation, is a rare manifestation associated with severe autoimmune disease.
Thyroid Storm
Definition and Importance
Thyroid storm is a rare but life-threatening endocrine emergency caused by severe exaggerated thyrotoxicosis. It represents decompensated hyperthyroidism associated with multi-organ dysfunction and carries high mortality if untreated.
This condition often develops in patients with untreated or poorly controlled hyperthyroidism following a precipitating event such as infection, surgery, trauma, myocardial infarction, diabetic ketoacidosis, or abrupt withdrawal of antithyroid medications.
Clinical Features of Thyroid Storm
Patients with thyroid storm present with severe hypermetabolic symptoms and systemic instability. High fever is characteristic and body temperature may exceed 40°C. Marked tachycardia, atrial fibrillation, heart failure, and circulatory collapse may occur.
Neurological manifestations include agitation, delirium, psychosis, confusion, seizures, and coma. Gastrointestinal symptoms such as nausea, vomiting, abdominal pain, and diarrhea are common. Severe dehydration and electrolyte imbalance frequently develop.
The severity of cardiovascular dysfunction often determines prognosis. Elderly patients may rapidly progress to heart failure and shock.
Management of Thyroid Storm
Management requires intensive care monitoring and rapid initiation of therapy. Treatment involves blocking thyroid hormone synthesis, preventing hormone release, controlling peripheral effects, and treating precipitating factors.
Beta blockers such as propranolol reduce adrenergic symptoms and heart rate. Propylthiouracil is preferred initially because it inhibits both thyroid hormone synthesis and peripheral T4-to-T3 conversion.
After antithyroid medication administration, iodine solutions are given to inhibit release of preformed thyroid hormones. Corticosteroids help reduce peripheral hormone conversion and may treat associated adrenal insufficiency.
Supportive measures include intravenous fluids, cooling therapy, oxygen supplementation, electrolyte correction, nutritional support, and treatment of infection or other triggering illnesses.
Early recognition and aggressive therapy are critical because untreated thyroid storm carries extremely high mortality.
Goiter
Definition and General Overview
Goiter refers to abnormal enlargement of the thyroid gland. The enlargement may involve the entire gland diffusely or may occur as nodular enlargement involving one or multiple nodules. Goiter itself is not a specific disease but rather a manifestation of various thyroid disorders. It may occur in patients with normal thyroid function, hypothyroidism, or hyperthyroidism.
Goiter is one of the most common thyroid abnormalities worldwide. In many regions, iodine deficiency remains the major cause, while autoimmune thyroid diseases and multinodular disease are more common in iodine-sufficient populations.
The thyroid gland enlarges in response to prolonged stimulation. Increased TSH secretion due to low thyroid hormone levels is one of the most important mechanisms. In other cases, autonomous nodules or autoimmune stimulation may produce thyroid enlargement independent of pituitary control.
The size of the goiter can vary from minimal enlargement detectable only on examination to massive enlargement causing cosmetic deformity and compressive symptoms involving the trachea or esophagus.
Causes of Goiter
The causes of goiter are diverse and include nutritional, autoimmune, inflammatory, congenital, and neoplastic conditions.
Iodine deficiency is a major cause globally because iodine is essential for thyroid hormone synthesis. Inadequate iodine intake leads to decreased thyroid hormone production, increased TSH secretion, and compensatory thyroid hyperplasia.
Graves disease causes diffuse toxic goiter through autoimmune stimulation of the TSH receptor. Hashimoto thyroiditis may initially produce thyroid enlargement due to lymphocytic infiltration and chronic inflammation.
Multinodular goiter develops through repeated cycles of hyperplasia and involution leading to nodular transformation of the gland. Toxic multinodular goiter may eventually produce hyperthyroidism.
Goiter may also occur during puberty, pregnancy, or periods of increased metabolic demand due to increased thyroid stimulation. Certain foods and medications interfere with thyroid hormone synthesis and are termed goitrogens. Examples include lithium, amiodarone, cassava, cabbage, and excessive soy intake.
Thyroid cysts, adenomas, and malignancies may also cause localized or diffuse enlargement of the gland.
Classification of Goiter
Goiter may be classified according to morphology and thyroid function.
Diffuse goiter involves uniform enlargement of the entire gland without discrete nodules. This pattern commonly occurs in Graves disease, early Hashimoto thyroiditis, and iodine deficiency.
Nodular goiter involves focal enlargement due to one or more nodules. A solitary thyroid nodule involves a single lesion, whereas multinodular goiter contains multiple nodules of varying size and activity.
Goiters may also be classified functionally. Toxic goiters produce excessive thyroid hormones and cause hyperthyroidism. Non-toxic goiters are not associated with hormone excess and may occur with normal or reduced thyroid function.
Endemic goiter occurs in populations where more than a significant proportion of individuals are affected, usually due to iodine deficiency. Sporadic goiter occurs without a clear geographic pattern.
Clinical Features of Goiter
The manifestations of goiter depend on its size, rate of growth, functional status, and underlying cause. Small goiters may be asymptomatic and discovered incidentally during physical examination or imaging studies.
Visible neck swelling is the most common finding. Patients may notice fullness or enlargement in the lower anterior neck. Large goiters can cause compressive symptoms due to pressure on adjacent structures.
Compression of the trachea may lead to cough, dyspnea, wheezing, or stridor. Esophageal compression may cause dysphagia, especially for solid foods. Recurrent laryngeal nerve involvement can produce hoarseness.
Retrosternal extension of large goiters into the mediastinum may cause venous congestion, facial flushing, dizziness, and superior vena cava obstruction.
Symptoms of thyroid dysfunction may coexist depending on the underlying condition. Hyperthyroid symptoms are seen in toxic goiters, while hypothyroid symptoms may occur in Hashimoto thyroiditis or severe iodine deficiency.
Pain and tenderness suggest inflammatory thyroid disease such as subacute thyroiditis or hemorrhage into a cyst.
Rapid enlargement, hard consistency, fixation to surrounding tissues, cervical lymphadenopathy, or vocal cord paralysis raise concern for thyroid malignancy.
Evaluation of Goiter
Evaluation begins with detailed history taking and physical examination. Important factors include duration of enlargement, rate of growth, symptoms of thyroid dysfunction, radiation exposure, family history, and compressive symptoms.
Physical examination assesses gland size, texture, tenderness, nodularity, mobility, and presence of cervical lymph nodes. A bruit may be heard in Graves disease due to increased vascularity.
Laboratory evaluation includes thyroid function tests such as TSH, free T4, and T3 levels. Autoantibody testing may help identify autoimmune thyroid disease.
Thyroid ultrasound is the most important imaging study for structural assessment. Ultrasound can determine gland size, identify nodules, assess vascularity, and distinguish cystic from solid lesions.
Radioactive iodine uptake scanning is useful when hyperthyroidism is present. Diffuse uptake suggests Graves disease, while focal uptake indicates toxic adenoma or multinodular goiter.
Computed tomography or magnetic resonance imaging may be required in very large goiters or substernal extension to evaluate airway compression and mediastinal involvement.
Fine needle aspiration cytology is indicated when suspicious nodules are present to exclude malignancy.
Thyroid Nodules
Definition and Epidemiology
Thyroid nodules are discrete lesions within the thyroid gland that differ radiologically or palpably from surrounding tissue. They are extremely common and increase in frequency with age. Many nodules are discovered incidentally during imaging performed for unrelated reasons.
Most thyroid nodules are benign, but a small proportion represent thyroid cancer. Therefore, careful evaluation is necessary to identify lesions requiring intervention.
Women are affected more commonly than men, and nodules occur more frequently in iodine-deficient regions and individuals exposed to radiation.
Causes of Thyroid Nodules
Benign colloid nodules are the most common cause. These nodules result from localized hyperplasia and colloid accumulation within the gland.
Follicular adenomas are benign neoplasms arising from follicular epithelium. Some may become autonomously functioning and produce hyperthyroidism.
Thyroid cysts may arise from degeneration or hemorrhage within nodules. Multinodular goiter commonly produces multiple nodular lesions of varying composition.
Inflammatory conditions such as Hashimoto thyroiditis may create pseudonodules due to focal lymphocytic infiltration.
Malignant causes include papillary thyroid carcinoma, follicular carcinoma, medullary carcinoma, anaplastic carcinoma, lymphoma, and metastatic disease.
Clinical Features of Thyroid Nodules
Most thyroid nodules are asymptomatic and discovered incidentally. Patients may notice a neck lump or fullness during swallowing or neck movement.
Large nodules may produce dysphagia, dyspnea, or cosmetic concerns. Hyperfunctioning nodules may cause symptoms of hyperthyroidism such as palpitations, weight loss, tremors, and heat intolerance.
Features raising suspicion for malignancy include rapid growth, hard consistency, fixation, cervical lymphadenopathy, hoarseness, history of childhood radiation exposure, and family history of thyroid cancer.
Pain is uncommon and may suggest hemorrhage into a cyst or inflammatory thyroid disease.
Evaluation of Thyroid Nodules
Initial evaluation includes thyroid function testing. Most patients are euthyroid, although low TSH levels suggest autonomous hormone production.
Thyroid ultrasound is the cornerstone of nodule evaluation. Important features assessed include size, echogenicity, margins, calcifications, vascularity, and shape.
Suspicious ultrasound features include microcalcifications, irregular borders, marked hypoechogenicity, taller-than-wide shape, and extrathyroidal extension.
Fine needle aspiration cytology is the most important diagnostic test for evaluating malignancy risk. It is usually recommended for nodules above specific size thresholds or nodules with suspicious imaging features.
Cytology results are commonly categorized using standardized systems that estimate malignancy risk and guide management.
Radioactive iodine scanning may identify hyperfunctioning nodules, which are rarely malignant. Cold nodules that fail to take up iodine have a higher likelihood of malignancy.
Molecular testing may be used in indeterminate nodules to improve diagnostic accuracy and guide surgical decisions.
Multinodular Goiter
Definition and Pathogenesis
Multinodular goiter is characterized by enlargement of the thyroid gland containing multiple nodules resulting from repeated cycles of follicular hyperplasia, degeneration, hemorrhage, and fibrosis.
The condition usually develops slowly over many years and is particularly common in older adults and iodine-deficient populations.
Initially, the gland may remain euthyroid, but autonomous nodules may eventually develop and produce toxic multinodular goiter with hyperthyroidism.
Clinical Features of Multinodular Goiter
Patients often present with irregular nodular enlargement of the thyroid gland. Large goiters may produce compressive symptoms including dyspnea, dysphagia, cough, and hoarseness.
Toxic multinodular goiter causes symptoms of hyperthyroidism, particularly cardiovascular manifestations such as atrial fibrillation and heart failure in elderly patients.
Retrosternal extension may cause tracheal compression and mediastinal symptoms.
Treatment of Multinodular Goiter
Management depends on gland size, symptoms, thyroid function, and malignancy risk.
Observation may be appropriate for asymptomatic euthyroid patients with small stable goiters.
Radioactive iodine therapy can reduce gland size and treat hyperthyroidism in toxic multinodular goiter.
Surgery is indicated for large symptomatic goiters, suspicion of malignancy, compressive symptoms, or cosmetic concerns. Total or near-total thyroidectomy is commonly performed in extensive disease.
.jpeg)
